Eran Bram

830 total citations
12 papers, 643 citations indexed

About

Eran Bram is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Eran Bram has authored 12 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Genetics. Recurrent topics in Eran Bram's work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (3 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Eran Bram is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (3 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Eran Bram collaborates with scholars based in Israel, United States and Netherlands. Eran Bram's co-authors include Yehuda G. Assaraf, Michal Stark, Saurabh Gupta, Ron Weiss, Shachar Raz, Andrzej Składanowski, Ilan Ifergan, Nitzan Gonen, Gerrit Jansen and Yael Mandel‐Gutfreund and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Eran Bram

12 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eran Bram Israel 12 398 235 91 68 56 12 643
Т. В. Наседкина Russia 14 393 1.0× 75 0.3× 106 1.2× 87 1.3× 20 0.4× 103 644
Christoph Schneider Switzerland 12 414 1.0× 134 0.6× 54 0.6× 14 0.2× 8 0.1× 23 789
Joana Cardoso Portugal 11 325 0.8× 147 0.6× 96 1.1× 112 1.6× 9 0.2× 24 576
Byron E. Wilson United States 11 400 1.0× 116 0.5× 50 0.5× 58 0.9× 12 0.2× 15 658
Sandrine A. Tinton Belgium 11 510 1.3× 86 0.4× 45 0.5× 56 0.8× 14 0.3× 13 719
Nagma Khan United Kingdom 5 702 1.8× 178 0.8× 50 0.5× 24 0.4× 19 0.3× 8 829
Alexis Leonard United States 18 331 0.8× 66 0.3× 113 1.2× 16 0.2× 126 2.3× 44 748
Catherine Sénamaud‐Beaufort France 15 694 1.7× 233 1.0× 99 1.1× 60 0.9× 20 0.4× 23 878
Ge Zhu China 14 388 1.0× 173 0.7× 34 0.4× 114 1.7× 10 0.2× 34 766
Pingfang Liu United States 17 833 2.1× 104 0.4× 93 1.0× 252 3.7× 17 0.3× 23 980

Countries citing papers authored by Eran Bram

Since Specialization
Citations

This map shows the geographic impact of Eran Bram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eran Bram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eran Bram more than expected).

Fields of papers citing papers by Eran Bram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eran Bram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eran Bram. The network helps show where Eran Bram may publish in the future.

Co-authorship network of co-authors of Eran Bram

This figure shows the co-authorship network connecting the top 25 collaborators of Eran Bram. A scholar is included among the top collaborators of Eran Bram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eran Bram. Eran Bram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Budimirovic, Dejan B., Annette Schlageter, Stela Filipovic-Sadic, et al.. (2020). A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments. Brain Sciences. 10(10). 694–694. 57 indexed citations
2.
Bram, Eran, Kamyab Javanmardi, Kimberly Nicholson, et al.. (2018). Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assay. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20(1-2). 107–114. 11 indexed citations
3.
Gupta, Saurabh, Eran Bram, & Ron Weiss. (2013). Genetically Programmable Pathogen Sense and Destroy. ACS Synthetic Biology. 2(12). 715–723. 94 indexed citations
4.
Stark, Michal, Eran Bram, Patrycja Nowak‐Sliwinska, et al.. (2012). Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death and Disease. 3(4). e293–e293. 83 indexed citations
5.
Stark, Michal, et al.. (2010). Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance. Journal of Biological Chemistry. 286(5). 3741–3754. 42 indexed citations
6.
Bram, Eran, Michal Stark, Shachar Raz, & Yehuda G. Assaraf. (2009). Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance. Neoplasia. 11(12). 1359–IN11. 97 indexed citations
7.
Beretta, Giovanni Luca, Valentina Benedetti, Giacomo Cossa, et al.. (2009). Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochemical Pharmacology. 79(8). 1108–1117. 90 indexed citations
8.
Bram, Eran, et al.. (2009). Structural Determinants of Imidazoacridinones Facilitating Antitumor Activity Are Crucial for Substrate Recognition by ABCG2. Molecular Pharmacology. 75(5). 1149–1159. 18 indexed citations
9.
Gonen, Nitzan, Eran Bram, & Yehuda G. Assaraf. (2008). PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells. Biochemical and Biophysical Research Communications. 376(4). 787–792. 35 indexed citations
10.
Bram, Eran, et al.. (2007). C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells. Biochemical Pharmacology. 74(1). 41–53. 38 indexed citations
11.
Bram, Eran, et al.. (2006). Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates. Cancer Chemotherapy and Pharmacology. 58(6). 826–834. 29 indexed citations
12.
Ifergan, Ilan, Eran Bram, Gerrit Jansen, et al.. (2005). ABCG2 Harboring the Gly482 Mutation Confers High-Level Resistance to Various Hydrophilic Antifolates. Cancer Research. 65(18). 8414–8422. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Т. В. Наседкина Breakdown of academic impact, for papers by Christoph Schneider Breakdown of academic impact, for papers by Joana Cardoso Breakdown of academic impact, for papers by Byron E. Wilson Breakdown of academic impact, for papers by Sandrine A. Tinton Breakdown of academic impact, for papers by Nagma Khan Breakdown of academic impact, for papers by Alexis Leonard Breakdown of academic impact, for papers by Catherine Sénamaud‐Beaufort Breakdown of academic impact, for papers by Ge Zhu Breakdown of academic impact, for papers by Pingfang Liu
Rankless by CCL
2026